aluates Reports

$ 0.0

Automative

Global RNAi Therapy Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-8Q14606

Global RNAi Therapy Market Research Report 2023

BUY CHAPTERS

Global RNAi Therapy Market Research Report 2025

Code: QYRE-Auto-8Q14606

Report

April 2025

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Alnylam

Sarepta Therapeutics

Alnylam Pharmaceuticals

Moderna, Inc

Sanofi

Arcturus Therapeutics

Silence

Sirnaomics

RNAi Therapy Market

The global market for RNAi Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

RNAi Therapy is a new treatment method that uses RNA interference (RNA interference, RNAi) to treat diseases. RNA interference refers to the introduction of double-stranded RNA molecules, so that the mRNA molecules of a specific gene cannot be translated into proteins, thereby achieving the purpose of inhibiting the expression of the gene. RNAi therapy utilizes the human body"s own gene regulation mechanism. It has strong targeting, good therapeutic effect, and few side effects. It is a new type of treatment with great potential.

North American market for RNAi Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for RNAi Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for RNAi Therapy in Oncology is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of RNAi Therapy include Alnylam, Sarepta Therapeutics, Alnylam Pharmaceuticals, Moderna, Sanofi, Arcturus Therapeutics, Silence, Sirnaomics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for RNAi Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNAi Therapy.

The RNAi Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global RNAi Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the RNAi Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of RNAi Therapy Market Report

Report Metric	Details
Report Name	RNAi Therapy Market
Segment by Type	Small Molecule Interfering Ribonucleic Acid (SiRNA) Microrna (MiRNA)
Segment by Application	Oncology Cardiology Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Alnylam, Sarepta Therapeutics, Alnylam Pharmaceuticals, Moderna, Sanofi, Arcturus Therapeutics, Silence, Sirnaomics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNAi Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the RNAi Therapy Market report?

Ans: The main players in the RNAi Therapy Market are Alnylam, Sarepta Therapeutics, Alnylam Pharmaceuticals, Moderna, Sanofi, Arcturus Therapeutics, Silence, Sirnaomics

What are the Application segmentation covered in the RNAi Therapy Market report?

Ans: The Applications covered in the RNAi Therapy Market report are Oncology, Cardiology, Others

What are the Type segmentation covered in the RNAi Therapy Market report?

Ans: The Types covered in the RNAi Therapy Market report are Small Molecule Interfering Ribonucleic Acid (SiRNA), Microrna (MiRNA)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global RNAi Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Small Molecule Interfering Ribonucleic Acid (SiRNA)

1.2.3 Microrna (MiRNA)

1.3 Market by Application

1.3.1 Global RNAi Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Oncology

1.3.3 Cardiology

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global RNAi Therapy Market Perspective (2020-2031)

2.2 Global RNAi Therapy Growth Trends by Region

2.2.1 Global RNAi Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 RNAi Therapy Historic Market Size by Region (2020-2025)

2.2.3 RNAi Therapy Forecasted Market Size by Region (2026-2031)

2.3 RNAi Therapy Market Dynamics

2.3.1 RNAi Therapy Industry Trends

2.3.2 RNAi Therapy Market Drivers

2.3.3 RNAi Therapy Market Challenges

2.3.4 RNAi Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top RNAi Therapy Players by Revenue

3.1.1 Global Top RNAi Therapy Players by Revenue (2020-2025)

3.1.2 Global RNAi Therapy Revenue Market Share by Players (2020-2025)

3.2 Global RNAi Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by RNAi Therapy Revenue

3.4 Global RNAi Therapy Market Concentration Ratio

3.4.1 Global RNAi Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by RNAi Therapy Revenue in 2024

3.5 Global Key Players of RNAi Therapy Head office and Area Served

3.6 Global Key Players of RNAi Therapy, Product and Application

3.7 Global Key Players of RNAi Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 RNAi Therapy Breakdown Data by Type

4.1 Global RNAi Therapy Historic Market Size by Type (2020-2025)

4.2 Global RNAi Therapy Forecasted Market Size by Type (2026-2031)

5 RNAi Therapy Breakdown Data by Application

5.1 Global RNAi Therapy Historic Market Size by Application (2020-2025)

5.2 Global RNAi Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America RNAi Therapy Market Size (2020-2031)

6.2 North America RNAi Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America RNAi Therapy Market Size by Country (2020-2025)

6.4 North America RNAi Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe RNAi Therapy Market Size (2020-2031)

7.2 Europe RNAi Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe RNAi Therapy Market Size by Country (2020-2025)

7.4 Europe RNAi Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific RNAi Therapy Market Size (2020-2031)

8.2 Asia-Pacific RNAi Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific RNAi Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific RNAi Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America RNAi Therapy Market Size (2020-2031)

9.2 Latin America RNAi Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America RNAi Therapy Market Size by Country (2020-2025)

9.4 Latin America RNAi Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa RNAi Therapy Market Size (2020-2031)

10.2 Middle East & Africa RNAi Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa RNAi Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa RNAi Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Alnylam

11.1.1 Alnylam Company Details

11.1.2 Alnylam Business Overview

11.1.3 Alnylam RNAi Therapy Introduction

11.1.4 Alnylam Revenue in RNAi Therapy Business (2020-2025)

11.1.5 Alnylam Recent Development

11.2 Sarepta Therapeutics

11.2.1 Sarepta Therapeutics Company Details

11.2.2 Sarepta Therapeutics Business Overview

11.2.3 Sarepta Therapeutics RNAi Therapy Introduction

11.2.4 Sarepta Therapeutics Revenue in RNAi Therapy Business (2020-2025)

11.2.5 Sarepta Therapeutics Recent Development

11.3 Alnylam Pharmaceuticals

11.3.1 Alnylam Pharmaceuticals Company Details

11.3.2 Alnylam Pharmaceuticals Business Overview

11.3.3 Alnylam Pharmaceuticals RNAi Therapy Introduction

11.3.4 Alnylam Pharmaceuticals Revenue in RNAi Therapy Business (2020-2025)

11.3.5 Alnylam Pharmaceuticals Recent Development

11.4 Moderna

11.4.1 Moderna Company Details

11.4.2 Moderna Business Overview

11.4.3 Moderna RNAi Therapy Introduction

11.4.4 Moderna Revenue in RNAi Therapy Business (2020-2025)

11.4.5 Moderna Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Details

11.5.2 Sanofi Business Overview

11.5.3 Sanofi RNAi Therapy Introduction

11.5.4 Sanofi Revenue in RNAi Therapy Business (2020-2025)

11.5.5 Sanofi Recent Development

11.6 Arcturus Therapeutics

11.6.1 Arcturus Therapeutics Company Details

11.6.2 Arcturus Therapeutics Business Overview

11.6.3 Arcturus Therapeutics RNAi Therapy Introduction

11.6.4 Arcturus Therapeutics Revenue in RNAi Therapy Business (2020-2025)

11.6.5 Arcturus Therapeutics Recent Development

11.7 Silence

11.7.1 Silence Company Details

11.7.2 Silence Business Overview

11.7.3 Silence RNAi Therapy Introduction

11.7.4 Silence Revenue in RNAi Therapy Business (2020-2025)

11.7.5 Silence Recent Development

11.8 Sirnaomics

11.8.1 Sirnaomics Company Details

11.8.2 Sirnaomics Business Overview

11.8.3 Sirnaomics RNAi Therapy Introduction

11.8.4 Sirnaomics Revenue in RNAi Therapy Business (2020-2025)

11.8.5 Sirnaomics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Alnylam

Sarepta Therapeutics

Alnylam Pharmaceuticals

Moderna, Inc

Sanofi

Arcturus Therapeutics

Silence

Sirnaomics

List of Tables

Table 1. Global RNAi Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Small Molecule Interfering Ribonucleic Acid (SiRNA)

Table 3. Key Players of Microrna (MiRNA)

Table 4. Global RNAi Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global RNAi Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global RNAi Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global RNAi Therapy Market Share by Region (2020-2025)

Table 8. Global RNAi Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global RNAi Therapy Market Share by Region (2026-2031)

Table 10. RNAi Therapy Market Trends

Table 11. RNAi Therapy Market Drivers

Table 12. RNAi Therapy Market Challenges

Table 13. RNAi Therapy Market Restraints

Table 14. Global RNAi Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global RNAi Therapy Market Share by Players (2020-2025)

Table 16. Global Top RNAi Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Therapy as of 2024)

Table 17. Ranking of Global Top RNAi Therapy Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by RNAi Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of RNAi Therapy, Headquarters and Area Served

Table 20. Global Key Players of RNAi Therapy, Product and Application

Table 21. Global Key Players of RNAi Therapy, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global RNAi Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global RNAi Therapy Revenue Market Share by Type (2020-2025)

Table 25. Global RNAi Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global RNAi Therapy Revenue Market Share by Type (2026-2031)

Table 27. Global RNAi Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global RNAi Therapy Revenue Market Share by Application (2020-2025)

Table 29. Global RNAi Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global RNAi Therapy Revenue Market Share by Application (2026-2031)

Table 31. North America RNAi Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America RNAi Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America RNAi Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe RNAi Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe RNAi Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe RNAi Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific RNAi Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific RNAi Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific RNAi Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America RNAi Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America RNAi Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America RNAi Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa RNAi Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa RNAi Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa RNAi Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 46. Alnylam Company Details

Table 47. Alnylam Business Overview

Table 48. Alnylam RNAi Therapy Product

Table 49. Alnylam Revenue in RNAi Therapy Business (2020-2025) & (US$ Million)

Table 50. Alnylam Recent Development

Table 51. Sarepta Therapeutics Company Details

Table 52. Sarepta Therapeutics Business Overview

Table 53. Sarepta Therapeutics RNAi Therapy Product

Table 54. Sarepta Therapeutics Revenue in RNAi Therapy Business (2020-2025) & (US$ Million)

Table 55. Sarepta Therapeutics Recent Development

Table 56. Alnylam Pharmaceuticals Company Details

Table 57. Alnylam Pharmaceuticals Business Overview

Table 58. Alnylam Pharmaceuticals RNAi Therapy Product

Table 59. Alnylam Pharmaceuticals Revenue in RNAi Therapy Business (2020-2025) & (US$ Million)

Table 60. Alnylam Pharmaceuticals Recent Development

Table 61. Moderna Company Details

Table 62. Moderna Business Overview

Table 63. Moderna RNAi Therapy Product

Table 64. Moderna Revenue in RNAi Therapy Business (2020-2025) & (US$ Million)

Table 65. Moderna Recent Development

Table 66. Sanofi Company Details

Table 67. Sanofi Business Overview

Table 68. Sanofi RNAi Therapy Product

Table 69. Sanofi Revenue in RNAi Therapy Business (2020-2025) & (US$ Million)

Table 70. Sanofi Recent Development

Table 71. Arcturus Therapeutics Company Details

Table 72. Arcturus Therapeutics Business Overview

Table 73. Arcturus Therapeutics RNAi Therapy Product

Table 74. Arcturus Therapeutics Revenue in RNAi Therapy Business (2020-2025) & (US$ Million)

Table 75. Arcturus Therapeutics Recent Development

Table 76. Silence Company Details

Table 77. Silence Business Overview

Table 78. Silence RNAi Therapy Product

Table 79. Silence Revenue in RNAi Therapy Business (2020-2025) & (US$ Million)

Table 80. Silence Recent Development

Table 81. Sirnaomics Company Details

Table 82. Sirnaomics Business Overview

Table 83. Sirnaomics RNAi Therapy Product

Table 84. Sirnaomics Revenue in RNAi Therapy Business (2020-2025) & (US$ Million)

Table 85. Sirnaomics Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

Table 89. Authors List of This Report

List of Figures

Figure 1. RNAi Therapy Picture

Figure 2. Global RNAi Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global RNAi Therapy Market Share by Type: 2024 VS 2031

Figure 4. Small Molecule Interfering Ribonucleic Acid (SiRNA) Features

Figure 5. Microrna (MiRNA) Features

Figure 6. Global RNAi Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global RNAi Therapy Market Share by Application: 2024 VS 2031

Figure 8. Oncology Case Studies

Figure 9. Cardiology Case Studies

Figure 10. Others Case Studies

Figure 11. RNAi Therapy Report Years Considered

Figure 12. Global RNAi Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global RNAi Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global RNAi Therapy Market Share by Region: 2024 VS 2031

Figure 15. Global RNAi Therapy Market Share by Players in 2024

Figure 16. Global Top RNAi Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Therapy as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by RNAi Therapy Revenue in 2024

Figure 18. North America RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America RNAi Therapy Market Share by Country (2020-2031)

Figure 20. United States RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe RNAi Therapy Market Share by Country (2020-2031)

Figure 24. Germany RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific RNAi Therapy Market Share by Region (2020-2031)

Figure 32. China RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America RNAi Therapy Market Share by Country (2020-2031)

Figure 40. Mexico RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa RNAi Therapy Market Share by Country (2020-2031)

Figure 44. Turkey RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Alnylam Revenue Growth Rate in RNAi Therapy Business (2020-2025)

Figure 48. Sarepta Therapeutics Revenue Growth Rate in RNAi Therapy Business (2020-2025)

Figure 49. Alnylam Pharmaceuticals Revenue Growth Rate in RNAi Therapy Business (2020-2025)

Figure 50. Moderna Revenue Growth Rate in RNAi Therapy Business (2020-2025)

Figure 51. Sanofi Revenue Growth Rate in RNAi Therapy Business (2020-2025)

Figure 52. Arcturus Therapeutics Revenue Growth Rate in RNAi Therapy Business (2020-2025)

Figure 53. Silence Revenue Growth Rate in RNAi Therapy Business (2020-2025)

Figure 54. Sirnaomics Revenue Growth Rate in RNAi Therapy Business (2020-2025)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global RNAi Therapeutics Market Research Report 2024

RNAi Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global RNAi for Therapeutic Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

RNAi Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global RNA Interference RNAi Based Therapeutics Market Research Report 2024

Global RNA Therapeutics Market Research Report 2024

RNAi Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vector Based RNAi Market Research Report 2024

Viral Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene Therapy based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Therapies for Cancer Treatment Market Research Report 2024

Gene based Advanced Therapy Medical Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene Therapy on Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antisense and RNAi Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Small Interfering RNA siRNA based Therapeutics Market Research Report 2024

Gene Delivery System Technology Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Gene Therapy Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions